Found: 82
Select item for more details and to access through your institution.
Pharmacokinetic and pharmacodynamic study of lenograstim for hematopoietic stem cell mobilization: a prospective randomized study for optimal apheresis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clinical Outcomes of Surgery after Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Ductal Adenocarcinoma.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 4, p. 1240, doi. 10.4143/crt.2023.977
- By:
- Publication type:
- Article
Clinical outcomes of immune checkpoint inhibitors in unresectable or metastatic combined hepatocellular–cholangiocarcinoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 10, p. 7547, doi. 10.1007/s00432-023-04704-3
- By:
- Publication type:
- Article
CT-determined resectability of borderline resectable and unresectable pancreatic adenocarcinoma following FOLFIRINOX therapy.
- Published in:
- European Radiology, 2021, v. 31, n. 2, p. 813, doi. 10.1007/s00330-020-07188-8
- By:
- Publication type:
- Article
Multiparametric MRI for prediction of treatment response to neoadjuvant FOLFIRINOX therapy in borderline resectable or locally advanced pancreatic cancer.
- Published in:
- European Radiology, 2021, v. 31, n. 2, p. 864, doi. 10.1007/s00330-020-07134-8
- By:
- Publication type:
- Article
Clinical impact of preoperative liver MRI in the evaluation of synchronous liver metastasis of colon cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Real-world data analysis of patients with cancer of unknown primary.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-02543-1
- By:
- Publication type:
- Article
A randomized study of the efficacy and safety of transdermal granisetron in the control of nausea and vomiting induced by moderately emetogenic chemotherapy in Korean patients.
- Published in:
- Supportive Care in Cancer, 2015, v. 23, n. 6, p. 1769, doi. 10.1007/s00520-014-2507-6
- By:
- Publication type:
- Article
Reduced and Normalized Carbohydrate Antigen 19-9 Concentrations after Neoadjuvant Chemotherapy Have Comparable Prognostic Performance in Patients with Borderline Resectable and Locally Advanced Pancreatic Cancer.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 5, p. 1477, doi. 10.3390/jcm9051477
- By:
- Publication type:
- Article
Estimation of population-based utility weights for gastric cancer-related health states.
- Published in:
- Patient Preference & Adherence, 2018, v. 12, p. 909, doi. 10.2147/PPA.S151946
- By:
- Publication type:
- Article
Real-world outcomes of adjuvant gemcitabine versus gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221097190
- By:
- Publication type:
- Article
Microsatellite Instability was not Associated with Survival in Stage III Colon Cancer Treated with Adjuvant Chemotherapy of Oxaliplatin and Infusional 5-Fluorouracil and Leucovorin (FOLFOX).
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2017, v. 24, n. 5, p. 1289, doi. 10.1245/s10434-016-5682-5
- By:
- Publication type:
- Article
Defective Mismatch Repair Status was not Associated with DFS and OS in Stage II Colon Cancer Treated with Adjuvant Chemotherapy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2015, v. 22, p. 630, doi. 10.1245/s10434-015-4807-6
- By:
- Publication type:
- Article
Comparison of gemcitabine plus cisplatin versus capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2017, v. 13, n. 1, p. 13, doi. 10.1111/ajco.12592
- By:
- Publication type:
- Article
Efficacy and safety of lanreotide in Korean patients with metastatic, well-differentiated gastroenteropancreatic-neuroendocrine tumors: a retrospective analysis.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 4, p. 763, doi. 10.1007/s10637-018-0710-x
- By:
- Publication type:
- Article
Prognostic factors in patients with metastatic or recurrent pancreatic cancer treated with first-line nab-paclitaxel plus gemcitabine: implication of inflammation-based scores.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 3, p. 584, doi. 10.1007/s10637-018-0681-y
- By:
- Publication type:
- Article
Phase I study of CKD-581, a pan-histone deacetylase inhibitor, in patients with lymphoma or multiple myeloma refractory to standard therapy.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 5, p. 877, doi. 10.1007/s10637-018-0582-0
- By:
- Publication type:
- Article
Nab-paclitaxel plus gemcitabine versus FOLFIRINOX as the first-line chemotherapy for patients with metastatic pancreatic cancer: retrospective analysis.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 4, p. 732, doi. 10.1007/s10637-018-0598-5
- By:
- Publication type:
- Article
Prognostic Implication of Inflammation-based Prognostic Scores in Patients with Intrahepatic Cholangiocarcinoma Treated with First-line Gemcitabine plus Cisplatin.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 3, p. 496, doi. 10.1007/s10637-017-0548-7
- By:
- Publication type:
- Article
Germline <italic>BRCA</italic> mutations in Asian patients with pancreatic adenocarcinoma: a prospective study evaluating risk category for genetic testing.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 1, p. 163, doi. 10.1007/s10637-017-0497-1
- By:
- Publication type:
- Article
First-in-human study of the toxicity, pharmacokinetics, and pharmacodynamics of CG200745, a pan-HDAC inhibitor, in patients with refractory solid malignancies.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 5, p. 1048, doi. 10.1007/s10637-015-0262-2
- By:
- Publication type:
- Article
Erratum to: Effect of simvastatin plus cetuximab/irinotecan for KRAS mutant colorectal cancer and predictive value of the RAS signature for treatment response to cetuximab.
- Published in:
- 2015
- By:
- Publication type:
- Erratum
Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211003053
- By:
- Publication type:
- Article
Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211003053
- By:
- Publication type:
- Article
FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920953294
- By:
- Publication type:
- Article
Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retrospective analysis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920923424
- By:
- Publication type:
- Article
Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study Group.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919871126
- By:
- Publication type:
- Article
Stereotactic Body Radiation Therapy versus Concurrent Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Propensity Score-Matched Analysis.
- Published in:
- Cancers, 2022, v. 14, n. 5, p. 1166, doi. 10.3390/cancers14051166
- By:
- Publication type:
- Article
Current Status and Future Perspectives of Perioperative Therapy for Resectable Biliary Tract Cancer: A Multidisciplinary Review.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1647, doi. 10.3390/cancers13071647
- By:
- Publication type:
- Article
Feasibility of HER2-Targeted Therapy in Advanced Biliary Tract Cancer: A Prospective Pilot Study of Trastuzumab Biosimilar in Combination with Gemcitabine Plus Cisplatin.
- Published in:
- Cancers, 2021, v. 13, n. 2, p. 161, doi. 10.3390/cancers13020161
- By:
- Publication type:
- Article
Clinical Outcomes of Conversion Surgery after Neoadjuvant Chemotherapy in Patients with Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer: A Single-Center, Retrospective Analysis.
- Published in:
- Cancers, 2019, v. 11, n. 3, p. 278, doi. 10.3390/cancers11030278
- By:
- Publication type:
- Article
Radiation therapy for recurrent extrahepatic bile duct cancer.
- Published in:
- PLoS ONE, 2021, v. 16, n. 6, p. 1, doi. 10.1371/journal.pone.0253285
- By:
- Publication type:
- Article
Clinical outcomes of systemic therapy in patients with unresectable or metastatic combined hepatocellular‐cholangiocarcinoma.
- Published in:
- Liver International, 2021, v. 41, n. 6, p. 1398, doi. 10.1111/liv.14813
- By:
- Publication type:
- Article
NPS-1034, a novel MET inhibitor, inhibits the activated MET receptor and its constitutively active mutants.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 3, p. 389, doi. 10.1007/s10637-013-0039-4
- By:
- Publication type:
- Article
Effect of simvastatin plus cetuximab/irinotecan for KRAS mutant colorectal cancer and predictive value of the RAS signature for treatment response to cetuximab.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 3, p. 535, doi. 10.1007/s10637-014-0065-x
- By:
- Publication type:
- Article
A prospective multicenter phase II study of sunitinib in patients with advanced aggressive fibromatosis.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 2, p. 369, doi. 10.1007/s10637-013-0059-0
- By:
- Publication type:
- Article
A phase I study of DHP107, a mucoadhesive lipid form of oral paclitaxel, in patients with advanced solid tumors: Crossover comparisons with intravenous paclitaxel.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 3, p. 616, doi. 10.1007/s10637-012-9841-7
- By:
- Publication type:
- Article
Multicenter phase II study of second-line bevacizumab plus doublet combination chemotherapy in patients with metastatic colorectal cancer progressed after upfront bevacizumab plus doublet combination chemotherapy.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 1, p. 183, doi. 10.1007/s10637-012-9853-3
- By:
- Publication type:
- Article
Biweekly cetuximab plus irinotecan as second-line chemotherapy for patients with irinotecan-refractory and KRAS wild-type metastatic colorectal cancer according to epidermal growth factor receptor expression status.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 4, p. 1607, doi. 10.1007/s10637-011-9703-8
- By:
- Publication type:
- Article
A phase I study of S-1 treatment with a 3 week schedule in advanced biliary cancer patients with or without hepatic dysfunction.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 2, p. 332, doi. 10.1007/s10637-009-9378-6
- By:
- Publication type:
- Article
Phase IB trial of ixabepilone and vorinostat in metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 167, n. 2, p. 469, doi. 10.1007/s10549-017-4516-x
- By:
- Publication type:
- Article
Epidemiology and Outcomes of Non–Small Cell Lung Cancer in South Korea.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 2, p. e2355331, doi. 10.1001/jamanetworkopen.2023.55331
- By:
- Publication type:
- Article
S100A14: A novel negative regulator of cancer stemness and immune evasion by inhibiting STAT3‐mediated programmed death‐ligand 1 expression in colorectal cancer.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 7, p. 1, doi. 10.1002/ctm2.986
- By:
- Publication type:
- Article
Expression of HER2 and Mismatch Repair Proteins in Surgically Resected Gallbladder Adenocarcinoma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.658564
- By:
- Publication type:
- Article
Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study Group.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919871126
- By:
- Publication type:
- Article
Efficacy of fluoropyrimidine-based chemotherapy in patients with advanced biliary tract cancer after failure of gemcitabine plus cisplatin: retrospective analysis of 321 patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Prognostic Value of the Microsatellite Instability Status in Patients With Stage II/III Rectal Cancer Following Upfront Surgery.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Disease severity-based evaluation of utility weights for lung cancer-related health states in Korea.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin: retrospective analysis of 740 patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Efficacy and safety of everolimus and sunitinib in patients with gastroenteropancreatic neuroendocrine tumor.
- Published in:
- 2017
- By:
- Publication type:
- journal article